Share to WeChat
Open WeChat, click “Discover” at the bottom, |
First Financial 2022-07-26 12:54:22
Editor in charge: Hao Yunying
On July 25, the State Food and Drug Administration, in accordance with the relevant provisions of the Drug Administration Law, conducted emergency review and approval in accordance with the special drug approval procedures, and approved the application for registration of real biological azvudine tablets for the treatment of new coronavirus pneumonia with conditions. In the morning, the reporter called Aoxiang Pharmaceutical as an investor. Its investor hotline said that when the announcement of the change was released in May 2022, it did sign a framework agreement for entrusted production with Real Biology, but it was only a framework agreement.
Aoxiang Pharmaceutical: The new crown oral drug is not an exclusive commissioned production details, but still need to sign a specific agreement丨Company Q&A
On July 25, the State Food and Drug Administration, in accordance with the relevant provisions of the Drug Administration Law, conducted emergency review and approval in accordance with the special drug approval procedures, and approved the application for registration of real biological azvudine tablets for the treatment of new coronavirus pneumonia with conditions. In the morning, the reporter called Aoxiang Pharmaceutical as an investor. Its investor hotline said that when the announcement of the change was released in May 2022, it did sign a framework agreement for entrusted production with Real Biology, but it was only a framework agreement.